semaglutide compounding news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Minnesota doctor says FDA weight-loss

This function is particularly important for children affected by metabolic disorders or genetic conditions that hinder natural carnitine production

10.1016/j.pharmthera.2020.107496 114 KoppF.MendellJ

Notably, while AP/NTS neurons express GLP-1Rs [3, 47], inhibiting GLP-1R-expressing AP neurons does not prevent the appetite-suppressing effects of endogenously released GLP-1 [39], likely because of low amounts of GLP-1 reaching these neurons due to rapid GLP-1 degradation by the enzyme dipeptidylpeptidase IV (DPPIV) [48]

Patel explains how oxidative stress affects the brain first, why inflammation is rising globally, and how restoring glutathione may help support clarity, recovery, and long-term cognitive performance

Tirzepatide, also known as Zepbound, is gaining attention as a powerful option

By increasing the amount of GLP-1 and GIP, the body produces more insulin, allowing more glucose to be transported from the blood to the cells that need it